Sign In
Buy ENLV
$0.611
-0.0122 (-1.96%)
At Close: Jun 23, 2026
What's in the Cards for Enlivex (ENLV) This Earnings Season?
01:44pm, Tuesday, 03'rd Nov 2020
Investors will be keen on pipeline updates when Enlivex Therapeutics (ENLV) reports results for the three months ending Sep 30, 2020.
Nes Ziona, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the Israeli Ministry of He
Nes Ziona, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the first patient has been dosed in an inves
\- Data show a 90% decrease in mortality with AllocetraTM treatment in a murine cecal ligation and puncture severe sepsis model Nes Ziona, Israel, July 20, 2020 -- Enlivex.
Enlivex Announces Allowance of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
12:30pm, Thursday, 18'th Jun 2020
Nes-Ziona, Israel, June 18, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Japan Patent Office (JPO) has issued a notice of all
Enlivex Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
12:00pm, Monday, 01'st Jun 2020
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday,
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that new analyses from its recently completed Phase Ib clinical trial of AllocetraTM in patients with sepsis
We're Not Very Worried About Enlivex Therapeutics's (NASDAQ:ENLV) Cash Burn Rate
10:56am, Wednesday, 20'th May 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Enlivex Announces Initiation of Multi-Center Phase II Investigator-Initiated Clinical Trial of Allocetra in COVID-19 Patients
12:00pm, Thursday, 07'th May 2020
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that an investigator-initiated multi-center Phase II clinical trial of AllocetraTM (formerly referred to as of
RIG, OKE among premarket gainers
01:21pm, Monday, 13'th Apr 2020
SCWorx (NASDAQ:WORX) +171% on order for 2M COVID-19 blood tests.Can-Fite BioPharma (NYSEMKT:CANF) +46% on study of lead drug in COVID-19.Independence Contract Drilling (NYSE:ICD) +32%.BioCryst Pha
Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials
12:25pm, Monday, 13'th Apr 2020
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s planned COVID-19 and sepsis clinical progr
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vaxart (
VXRT
–
Research Report
), Enlivex Therapeutics (
ENLV
–
Research Report
) and Capricor The
SLS, APRN among premarket gainers
01:23pm, Wednesday, 18'th Mar 2020
Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N
Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
12:00pm, Wednesday, 18'th Mar 2020
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, today announced positive final safety and efficacy data from the Company’s completed Phase Ib clinical trial in patients wit
INO, DXC among premarket gainers
01:16pm, Wednesday, 11'th Mar 2020
Tiziana Life Sciences PLC (NASDAQ:TLSA) +162% on potential coronavirus treatment.Phio Pharmaceuticals (NASDAQ:PHIO) +24% on Medigene deal.Inovio Pharmaceuticals (NASDAQ:INO) +21%.Altimmune (NASDAQ:A
